PODOFILOX Drug Patent Profile
✉ Email this page to a colleague
When do Podofilox patents expire, and when can generic versions of Podofilox launch?
Podofilox is a drug marketed by Padagis Us and Bausch And Lomb Inc and is included in three NDAs.
The generic ingredient in PODOFILOX is podofilox. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the podofilox profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Podofilox
A generic version of PODOFILOX was approved as podofilox by PADAGIS US on January 29th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PODOFILOX?
- What are the global sales for PODOFILOX?
- What is Average Wholesale Price for PODOFILOX?
Summary for PODOFILOX
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 93 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,990 |
| Drug Prices: | Drug price information for PODOFILOX |
| What excipients (inactive ingredients) are in PODOFILOX? | PODOFILOX excipients list |
| DailyMed Link: | PODOFILOX at DailyMed |
Recent Clinical Trials for PODOFILOX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hyloris Developments SA | Phase 3 |
| bioRASI, LLC | Phase 3 |
| Dermax SA | Phase 3 |
Pharmacology for PODOFILOX
| Physiological Effect | Decreased Mitosis |
US Patents and Regulatory Information for PODOFILOX
PODOFILOX is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting PODOFILOX
COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | PODOFILOX | podofilox | GEL;TOPICAL | 211871-001 | Nov 22, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bausch And Lomb Inc | PODOFILOX | podofilox | SOLUTION;TOPICAL | 090184-001 | Jul 21, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Padagis Us | PODOFILOX | podofilox | SOLUTION;TOPICAL | 075600-001 | Jan 29, 2002 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
